Morgan Stanley Genocea Biosciences, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $281 - $38,864	-28,163 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$0.96 - $1.35 $27,036 - $38,020	28,163 New	28,163 $35,000
Q1 2022 May 13, 2022	BUY	$0.96 - $1.35 $13,945 - $19,611	14,527 Added 106.53%	28,163 $35,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.99 $1,931 - $4,045	-2,033 Reduced 12.97%	13,636 $15,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.33 $27,264 - $36,508	15,669 New	15,669 $30,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.